Загрузка...
CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma
Establishing the diagnosis of focal brain lesions in patients with unexplained neurologic symptoms represents a challenge. The goal of this study is to provide evidence supporting functional roles for CXC chemokine ligand (CXCL)13 and interleukin (IL)-10 in central nervous system (CNS) lymphomas and...
Сохранить в:
Главные авторы: | , , , , , , , , , , , , , , , , |
---|---|
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
American Society of Hematology
2013
|
Предметы: | |
Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3674672/ https://ncbi.nlm.nih.gov/pubmed/23570798 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-01-476333 |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|